These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 21074634)

  • 41. Drug discovery beyond the 'rule-of-five'.
    Zhang MQ; Wilkinson B
    Curr Opin Biotechnol; 2007 Dec; 18(6):478-88. PubMed ID: 18035532
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Knowledge-based chemoinformatic approaches to drug discovery.
    Ghose AK; Herbertz T; Salvino JM; Mallamo JP
    Drug Discov Today; 2006 Dec; 11(23-24):1107-14. PubMed ID: 17129830
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Strategy of molecular drug design: hits, leads and drug candidates].
    Guo ZR
    Yao Xue Xue Bao; 2008 Sep; 43(9):898-904. PubMed ID: 19048779
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Circular fingerprints: flexible molecular descriptors with applications from physical chemistry to ADME.
    Glem RC; Bender A; Arnby CH; Carlsson L; Boyer S; Smith J
    IDrugs; 2006 Mar; 9(3):199-204. PubMed ID: 16523386
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Physicochemical property trends of marketed prodrugs.
    Landis MS
    Ther Deliv; 2013 Feb; 4(2):225-37. PubMed ID: 23343161
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthetic library design.
    Huwe CM
    Drug Discov Today; 2006 Aug; 11(15-16):763-7. PubMed ID: 16846805
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessment of the consistency of medicinal chemists in reviewing sets of compounds.
    Lajiness MS; Maggiora GM; Shanmugasundaram V
    J Med Chem; 2004 Sep; 47(20):4891-6. PubMed ID: 15369393
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Strategies to improve oral drug bioavailability.
    Gomez-Orellana I
    Expert Opin Drug Deliv; 2005 May; 2(3):419-33. PubMed ID: 16296764
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Strategy of molecular drug design: activity and druggability].
    Guo ZR
    Yao Xue Xue Bao; 2010 May; 45(5):539-47. PubMed ID: 20931752
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Drug and drug candidate building block analysis.
    Wang J; Hou T
    J Chem Inf Model; 2010 Jan; 50(1):55-67. PubMed ID: 20020714
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Improving oral delivery.
    Gabor F; Fillafer C; Neutsch L; Ratzinger G; Wirth M
    Handb Exp Pharmacol; 2010; (197):345-98. PubMed ID: 20217536
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Design of multiple targeted drugs].
    Guo YS; Guo ZR
    Yao Xue Xue Bao; 2009 Mar; 44(3):276-81. PubMed ID: 19449524
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Metal complexes in medicinal chemistry: new vistas and challenges in drug design.
    Thompson KH; Orvig C
    Dalton Trans; 2006 Feb; (6):761-4. PubMed ID: 16437168
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Using in vitro human tissues to predict pharmacokinetic properties.
    Huebert ND; Dasgupta M; Chen Y
    Curr Opin Drug Discov Devel; 2004 Jan; 7(1):69-74. PubMed ID: 14982150
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Drug Discovery Portal: a resource to enhance drug discovery from academia.
    Clark RL; Johnston BF; Mackay SP; Breslin CJ; Robertson MN; Harvey AL
    Drug Discov Today; 2010 Aug; 15(15-16):679-83. PubMed ID: 20547242
    [TBL] [Abstract][Full Text] [Related]  

  • 56. How drug-like are 'ugly' drugs: do drug-likeness metrics predict ADME behaviour in humans?
    Ritchie TJ; Macdonald SJ
    Drug Discov Today; 2014 Apr; 19(4):489-95. PubMed ID: 24462956
    [TBL] [Abstract][Full Text] [Related]  

  • 57. When poor solubility becomes an issue: from early stage to proof of concept.
    Stegemann S; Leveiller F; Franchi D; de Jong H; Lindén H
    Eur J Pharm Sci; 2007 Aug; 31(5):249-61. PubMed ID: 17616376
    [TBL] [Abstract][Full Text] [Related]  

  • 58. What do medicinal chemists actually make? A 50-year retrospective.
    Walters WP; Green J; Weiss JR; Murcko MA
    J Med Chem; 2011 Oct; 54(19):6405-16. PubMed ID: 21755928
    [No Abstract]   [Full Text] [Related]  

  • 59. Recent advances in intravenous delivery of poorly water-soluble compounds.
    Shi Y; Porter W; Merdan T; Li LC
    Expert Opin Drug Deliv; 2009 Dec; 6(12):1261-82. PubMed ID: 19941409
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ADME evaluation in drug discovery. 6. Can oral bioavailability in humans be effectively predicted by simple molecular property-based rules?
    Hou T; Wang J; Zhang W; Xu X
    J Chem Inf Model; 2007; 47(2):460-3. PubMed ID: 17381169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.